AbbVie Acquires Capstan Therapeutics for $2.1B, Gaining In Vivo CAR-T Platform Targeting Autoimmune Diseases

AbbVie announced a definitive agreement to acquire Capstan Therapeutics for up to $2.1 billion in cash, gaining access to its targeted …

Continue ›››

Chai Discovery Releases All-Atom Foundation Model for Zero-Shot Antibody Design with 16–20% Hit Rates

Chai Discovery has released Chai-2, a generative molecular design model for zero-shot antibody and binder discovery. The model is capable …

Continue ›››

Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome

With DeepMind’s release of AlphaGenome—a deep learning model that can predict the relevance of variants in both coding and non-coding …

Continue ›››

Arc Institute Opens Virtual Cell Challenge With $175K in AI Benchmarking Prizes

The Arc Institute has launched the Virtual Cell Challenge, a new open competition to benchmark computational models that predict how …

Continue ›››

SandboxAQ Releases Public Database Containing 5.2 Million Synthetic Protein-Ligand Structures

SandboxAQ has launched what it claims is the largest public dataset of protein-ligand complexes with associated binding affinity data. The …

Continue ›››

DeepMind Introduces AlphaGenome for Predicting Effects of Human DNA Variants

A new AI model from Google DeepMind, called AlphaGenome, has been released in preview for non-commercial research, offering a high-resolution, …

Continue ›››

AI Drug Discovery Firm XtalPi Secures $100M Upfront in a Deal with DoveTree, Eyes $10B+ in Milestones

XtalPi has signed a letter of intent with DoveTree LLC, a company founded by Harvard University professor Gregory Verdine, to …

Continue ›››

Arc Institute Releases its First Virtual Cell Model

Arc Institute has launched its first virtual cell model, State, designed to predict gene expression changes in response to chemical, genetic, …

Continue ›››

NVIDIA Releases Agentic AI Blueprint for Literature Review and Target Discovery

NVIDIA has released a new AI-driven workflow, the Biomedical AI-Q Research Agent Developer Blueprint, designed to accelerate the early phases …

Continue ›››

Nabla Raises $70M Series C to Expand Agentic AI Platform for Clinical Workflows

Nabla, developer of a widely adopted AI assistant used by over 130 healthcare organizations, has raised a $70 million Series …

Continue ›››

Axiom Bio Releases Human Liver Toxicity Dataset with 130,000 Compounds to Advance AI-based Toxicity Prediction

San Francisco-based startup Axiom Bio, previously backed by $15 million in seed funding from investors including Amplify Partners, Dimension Capital, …

Continue ›››

Xaira Publishes Largest Public Perturb-seq Atlas to Advance Virtual Cell Modeling

Xaira Therapeutics has announced the release of "X-Atlas/Orion", a large genome-wide Perturb-seq dataset, reportedly the largest publicly available resource of its …

Continue ›››